Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$6.02
0.0761.28%
Last update: Dec 15, 9:04 AM
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy MannKind (MNKD) stock?
You can purchase shares of MannKind (NASDAQ:MNKD) through any online brokerage.
Who are MannKind (MNKD) competitors?
Other companies in MannKind’s space includes: Immunome Inc (NASDAQ:IMNM), Twist Bioscience Corp (NASDAQ:TWST), Upstream Bio Inc (NASDAQ:UPB), Syndax Pharmaceuticals Inc (NASDAQ:SNDX) and NuCana PLC (NASDAQ:NCNA).
What is the forecast, or price target, for MannKind (MNKD) stock?
MannKind has a consensus price target of $9.61.
What is the current price for MannKind (MNKD)?
The stock price for MannKind (NASDAQ: MNKD) is $6.016 last updated December 15, 2025 at 9:04 AM EST.
Does MannKind (MNKD) pay a dividend?
There are no upcoming dividends for MannKind.
When is MannKind (NASDAQ:MNKD) reporting earnings?
MannKind does not have any upcoming earnings scheduled.
Is MannKind (MNKD) going to split?
There is no upcoming split for MannKind.
What sector and industry does MannKind (MNKD) operate in?
MannKind is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
